Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to collect real-world data in order to estimate the frequency of overall malignancies, melanoma, basal cell carcinoma, and squamous cell carcinoma in participants with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) enrolled in the SRQ Register in Sweden.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Abatacept Group | Participants with established RA or PsA and receiving abatacept. | ||
| Non-targeted Disease Modifying Anti-rheumatic Drug (DMARD) Group | Participants with established RA or PsA and not previously treated with any targeted DMARDs and who start treatment with a non-targeted DMARD. | ||
| Targeted DMARD Group | Participants with established RA or PsA and previously treated without abatacept who start treatment with targeted DMARDs. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence Rate of Overall Malignancies | 5 years | |
| Incidence Rate of Melanoma | 5 years | |
| Incidence Rate of Non-melanoma Skin Cancer | 5 years | |
| Incidence Rate of Basal Cell Carcinoma | 5 years | |
| Incidence Rate of Squamous Cell Carcinoma | 5 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Not applicable
Not provided
Not provided
Not provided
Participants with RA or PsA who began abatacept, a non-targeted DMARD, or a targeted DMARD enrolled in the SRQ Register between January 2007 and January 2021.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bristol-Myers Squibb | Bristol-Myers Squibb | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Local Institution | Princeton | New Jersey | 08540 | United States |
Not provided
| Label | URL |
|---|---|
| BMS Clinical Trial Information | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| D015535 | Arthritis, Psoriatic |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D003240 |
| Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D025242 | Spondylarthropathies |
| D025241 | Spondylarthritis |
| D013166 | Spondylitis |
| D013122 | Spinal Diseases |
| D001847 | Bone Diseases |
| D011565 | Psoriasis |
| D017444 | Skin Diseases, Papulosquamous |
| D012871 | Skin Diseases |